financetom
Business
financetom
/
Business
/
Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US
May 13, 2024 6:39 AM

09:07 AM EDT, 05/13/2024 (MT Newswires) -- Novo Nordisk ( NVO ) , based in Denmark, has been asked by Bernie Sanders of Vermont to reduce the prices of its Ozempic and Wegovy drugs in the US, multiple media outlets reported Monday, citing a column published by the US senator in Danish newspaper Politiken.

Ozempic costs 6,700 Danish kroner ($969.6) per month in the US, while it is sold for less than 500 kroner in other countries, Sanders wrote in the column for Politiken.

Sanders urged Denmark's government to put pressure on Novo Nordisk ( NVO ) to lower the prices of the two drugs, the outlets reported, citing the column.

Neither Novo Nordisk ( NVO ) nor the senator's office immediately responded to MT Newswires' requests for comment.

Price: 131.40, Change: +2.98, Percent Change: +2.32

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
JELD-WEN Swings to Fiscal Q3 Loss, Revenue Falls; Trims 2025 Revenue Guidance
JELD-WEN Swings to Fiscal Q3 Loss, Revenue Falls; Trims 2025 Revenue Guidance
Nov 4, 2025
05:08 AM EST, 11/04/2025 (MT Newswires) -- JELD-WEN ( JELD ) reported a fiscal Q3 adjusted loss Monday of $0.20 per share, swinging from earnings of $0.32 a year earlier. Analysts polled by FactSet expected earnings of $0.14. Revenue for the quarter ended Sept. 27 was $809.5 million, compared with $934.7 million a year earlier. Analysts polled by FactSet expected...
Telefonica Reports Q3 Earnings, Lower Revenue; Shares Down Pre-Bell
Telefonica Reports Q3 Earnings, Lower Revenue; Shares Down Pre-Bell
Nov 4, 2025
05:11 AM EST, 11/04/2025 (MT Newswires) -- Telefonica ( TEF ) reported Q3 earnings Tuesday of 0.04 euro ($0.046) per share, swinging from a loss of 0.01 euro a year earlier. Two analysts surveyed by FactSet expected EPS of 0.08 euro. Revenue for the three months ended Sept. 30 was 8.96 billion euros, down from 9.10 billion euros a year...
Denny's to be Acquired in $620 Million Deal; Shares Up Pre-Bell
Denny's to be Acquired in $620 Million Deal; Shares Up Pre-Bell
Nov 4, 2025
04:41 AM EST, 11/04/2025 (MT Newswires) -- Denny's (DENN) said late Monday it agreed to be acquired by TriArtisan Capital Advisors, Treville Capital Group, and Yadav Enterprises for $6.25 per share in cash, implying an enterprise value of about $620 million. The purchase price represents a 52% premium to Denny's Monday closing stock price. Denny's will become a private company...
Update: Super Group Q3 Earnings, Revenue Rise; Shares Gain Pre-Bell
Update: Super Group Q3 Earnings, Revenue Rise; Shares Gain Pre-Bell
Nov 4, 2025
05:13 AM EST, 11/04/2025 (MT Newswires) -- (Updates with recent stock movement in the headline and first paragraph.) Super Group (SGHC) shares were more than 19% higher in premarket activity Tuesday after the company reported late Monday an increase in Q3 earnings and sales that exceeded market expectations. The company reported Q3 earnings of $0.19 per diluted share, up from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved